Neurocrine Bioscience buy UBS Group AG
Start price
04.04.25
/
50%
€86.72
Target price
04.04.26
€123.79
Performance (%)
53.42%
Price
10.12.25
€133.05
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Neurocrine Bioscience has seen massive gains of 53.42%. This prediction currently runs until 04.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.150% | 2.150% |
| iShares Core DAX® | 1.803% | 0.496% |
| iShares Nasdaq 100 | 0.429% | -0.410% |
| iShares Nikkei 225® | 0.708% | -3.799% |
| iShares S&P 500 | 0.288% | -0.218% |
Comments by UBS_Group_AG for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at UBS Group AG from $154.00 to $137.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.80
09.10.25
09.10.25
€167.52
09.10.26
09.10.26
11.06%
10.12.25
10.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€113.95
09.07.25
09.07.25
€148.44
09.07.26
09.07.26
16.76%
10.12.25
10.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.15
06.05.25
06.05.25
€134.58
06.05.26
06.05.26
23.02%
10.12.25
10.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
08.01.25
08.01.25
€157.20
08.01.26
08.01.26
-1.44%
10.12.25
10.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.45
28.05.24
28.05.24
€177.37
28.05.25
28.05.25
-13.52%
29.05.25
29.05.25